Lifecome Biochemistry Hits Day Low of CNY 32.77 Amid Price Pressure

Lifecome Biochemistry Co., Ltd. experienced a significant decline in its stock price today, dropping by 7.58% and reaching an intraday low of CNY 32.77. This performance stands in stark contrast to the China Shanghai Composite, which gained 0.96% on the same day. Over the past week, Lifecome's stock has decreased by 7.48%, and its monthly performance reflects a decline of 13.09%. Despite a notable annual increase of 40.56%, the company's year-to-date performance shows a slight decrease of 0.18%. In the context of longer-term performance, Lifecome has faced challenges, with a three-year decline of 13.65%, although it has seen a remarkable five-year growth of 207.03%. Key financial metrics indicate that Lifecome is currently net-debt free, yet it has struggled with profitability, as evidenced by a low Return on Capital Employed (ROCE) of 0.86% and a Return on Equity (ROE) of -149.66%. The company's market capitalization stands at CNY 5,648 million, placing it in the mid-cap category within the Pharmaceuticals & Biotechnology industry.